Compass Therapeutics Inc. (CMPX) — Defensive Interval Ratio
Compass Therapeutics Inc. (CMPX) has a Defensive Interval Ratio of 4954 days as of March 2026. Defensive assets of $139.52 Million (cash $-, short-term investments $139.52 Million, receivables $-) cover 4954 days of daily cash needs of $28.16K/day. See CMPX working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Compass Therapeutics Inc. Defensive Interval Ratio (2021–2025)
This chart shows how Compass Therapeutics Inc.'s Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 4954 days, meaning defensive assets of $139.52 Million can fund 4954 days of operations without new revenue. See debt-free asset ratio of Compass Therapeutics Inc. to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Compass Therapeutics Inc. (2021–2025)
The table below presents the year-by-year Defensive Interval Ratio for Compass Therapeutics Inc. from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see CMPX market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4658 days | $178.26 Million | $38.27K/day | $- | $178.26 Million | ▲ +1234 days |
| 2024 | 3424 days | $83.24 Million | $24.31K/day | $- | $83.24 Million | ▼ -2576 days |
| 2023 | 6000 days | $128.23 Million | $21.37K/day | $- | $128.23 Million | ▲ +2569 days |
| 2022 | 3431 days | $151.98 Million | $44.30K/day | $- | $151.66 Million | ▲ +3431 days |
| 2021 | 0 days | $0.00 | $29.13K/day | $- | $0.00 | — |